ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,084.19
0.82%
US Tech 100
21,162.00
-0.16%
Dow Jones
44,148.56
-0.22%
Brent Oil
73.61
0.22%
Bitcoin
100,846.28
-0.34%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oric Pharmaceuticals Inc (ORIC)

  7. Oric Pharmaceuticals Inc (ORIC) News

Oric Pharmaceuticals Inc

Oric Pharmaceuticals Inc (ORIC)

NASDAQ
8.96
-0.06
(-0.67%)
Closed December 11 4:00PM
Delayed by 15 minutes
8.96
0.00
( 0.00% )
Pre Market: 4:05AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

ORIC News

Official News Only

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Edgar (US Regulatory)
November 14 2024
ORIC (-0.67%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 12 2024
ORIC (-0.67%)

Form 8-K - Current report
Edgar (US Regulatory)
November 12 2024
ORIC (-0.67%)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
November 08 2024
ORIC (-0.67%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
August 12 2024
ORIC (-0.67%)

Form 8-K - Current report
Edgar (US Regulatory)
August 12 2024
ORIC (-0.67%)

ORIC Discussion

View Posts
Monksdream Monksdream 3 months ago
ORIC under $10
👍️0
Monksdream Monksdream 5 months ago
ORIC under $10
👍️0
Monksdream Monksdream 5 months ago
ORIC under $10
👍️0
Monksdream Monksdream 7 months ago
ORIC 10Q due 5/6
👍️0
Monksdream Monksdream 7 months ago
ORIC under $10
👍️0
Monksdream Monksdream 9 months ago
ORIC 10Q due 3/16
👍️0
Monksdream Monksdream 9 months ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 9 months ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 9 months ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 10 months ago
ORIC new 52 weewk high
👍️0
Monksdream Monksdream 11 months ago
ORIC new 52 week high
👍️0
TheFinalCD TheFinalCD 2 years ago
$ORIC LOOKS LIKE $6 COMING
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: Tapped $5.40....... still got steam

It ain't over yet





GO $ORIC
👍️0
DH112 DH112 2 years ago
Today is green fields
👍️0
TheFinalCD TheFinalCD 2 years ago
Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: 5.25 now........................... lets get to $10

I know you can do it babyyyyyyyyyyyyyyyyy


GO $ORIC
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC : Now at 4.90

YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

Me likes it


GO $ORIC
👍️0
crudeoil24 crudeoil24 2 years ago
Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.


Write to Dean Seal at dean.seal@wsj.com


(END) Dow Jones Newswires

December 22, 2022 07:25 ET (12:25 GMT)
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

Letssssssss goooooooooooooooooo.


Added 5k shares here at 4.30

Great NEWS


https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

GO $ORIC
👍️0

Your Recent History

NASDAQ
ORIC
Oric Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved